BIOG Biotech Growth Trust

Edison issues report on The Biotech Growth Trust (BIOG)

Edison Investment Research Limited
Edison issues report on The Biotech Growth Trust (BIOG)

20-Aug-2024 / 12:07 GMT/BST
The issuer is solely responsible for the content of this announcement.


 

London, UK, 20 August 2024

 

Edison issues report on The Biotech Growth Trust (BIOG)

Edison issues report on The Biotech Growth Trust (LSE: BIOG) to read the full report.

All reports published by Edison are available to download free of charge from its website

Edison is authorised and regulated by the .

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison’s reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

+44 (0)20 3077 5700

Connect with Edison on:

 

LinkedIn 

X  

YouTube 



Dissemination of a CORPORATE NEWS, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1971611  20-Aug-2024 

fncls.ssp?fn=show_t_gif&application_id=1971611&application_name=news&site_id=research_pool~~~9efe1c65-8ece-4ff7-9608-f21c8e0a38a3
EN
20/08/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Biotech Growth Trust

 PRESS RELEASE

Edison issues report on The Biotech Growth Trust (BIOG)

Edison Investment Research Limited Edison issues report on The Biotech Growth Trust (BIOG) 18-March-2025 / 15:47 GMT/BST The issuer is solely responsible for the content of this announcement.   London, UK, 18 March 2025   Edison issues report on The Biotech Growth Trust (BIOG) Edison issues report on The Biotech Growth Trust (LSE: BIOG) The Biotech Growth Trust’s (BIOG’s) highly experienced managers, Geoff Hsu and Josh Golomb, are able to draw on the considerable resources of global healthcare specialist OrbiMed. BIOG’s performance has been particularly challenging as the m...

Biotech Growth Trust: 1 director

A director at Biotech Growth Trust bought 3,000 shares at 931p and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...

 PRESS RELEASE

Edison issues report on The Biotech Growth Trust (BIOG)

Edison Investment Research Limited Edison issues report on The Biotech Growth Trust (BIOG) 20-Aug-2024 / 12:07 GMT/BST The issuer is solely responsible for the content of this announcement.   London, UK, 20 August 2024   Edison issues report on The Biotech Growth Trust (BIOG) Edison issues report on The Biotech Growth Trust (LSE: BIOG) to read the full report. All reports published by Edison are available to download free of charge from its website Edison is authorised and regulated by the . Edison is not an adviser or broker-dealer and does not provide investment advic...

Pedro Fonseca
  • Pedro Fonseca

The Biotech Growth Trust - Valuations starting to improve with more to...

The Biotech Growth Trust (BIOG) has two experienced managers, Geoff Hsu and Josh Golomb, at leading global healthcare specialist OrbiMed. They remain very positive on the outlook for the biotech sector, believing that industry valuations became disconnected from positive industry fundamentals during a period of elevated interest rates. BIOG’s strategy favours emerging (smaller-cap) over large-cap biotech companies, as, while aggregate risks are higher, they can be more than outweighed by superio...

 PRESS RELEASE

Edison issues update on The Biotech Growth Trust (BIOG): Onwards and u...

Edison Investment Research Limited Edison issues update on The Biotech Growth Trust (BIOG): Onwards and upwards for performance recovery 20-March-2024 / 09:09 GMT/BST The issuer is solely responsible for the content of this announcement.   London, UK, 20 March 2024   Edison issues update on The Biotech Growth Trust (BIOG): Onwards and upwards for performance recovery The Biotech Growth Trust’s (BIOG’s) two co-managers, Geoff Hsu and Josh Golomb, at global healthcare specialist OrbiMed, believe that now could be an opportune time to consider the biotech sector as it is recover...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch